Literature DB >> 6849909

Effects of liposome size on the degradation of bovine brain sphingomyelin/cholesterol liposomes in the mouse liver.

P L Beaumier, K J Hwang.   

Abstract

The relative rates of degradation of the outer lipid bilayer of large multilamellar and small unilamellar bovine brain sphingomyelin/cholesterol (2:1; mol/mol) liposomes in the livers of Balb/c mice were compared. The rate of the release of entrapped In-111 ions from the aqueous reservoir of small unilamellar liposomes or from the outermost aqueous compartment of multilamellar liposomes was used to monitor the rate of degradation of the exterior lipid bilayer surface of these liposomes. The technique of gamma-ray perturbed angular correlation and a method for loading In-111 ions into the outermost aqueous compartment of liposomes were used in this investigation. It was found that in the liver the exterior lipid bilayer of large multilamellar liposomes was degraded more rapidly than the bilayer of small unilamellar liposomes in vivo. In contrast to the situation for small unilamellar liposomes, the degradative process for large multilamellar liposomes in the liver was not maintained under ischemic conditions. Our results suggest that multiple pathways operate in the degradation of liposomes in the liver. The rate of degradation of liposomes in the liver may depend on accessibility of liposomes to degradative sites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849909     DOI: 10.1016/0005-2736(83)90393-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Species difference in the disposition of liposomes among mice, rats, and rabbits: allometric relationship and species dependent hepatic uptake mechanism.

Authors:  H Harashima; S Komatsu; S Kojima; C Yanagi; Y Morioka; M Naito; H Kiwada
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

2.  Effects of chronic injection of sphingomyelin-containing liposomes on lymphoid and non-lymphoid cells in the spleen. Transient suppression of marginal zone macrophages.

Authors:  E Claassen; Y Westerhof; B Versluis; N Kors; M Schellekens; N van Rooijen
Journal:  Br J Exp Pathol       Date:  1988-12

Review 3.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

4.  Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.

Authors:  H Harashima; K Sakata; H Kiwada
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

5.  Toxicity of sphingomyelin-containing liposomes after chronic injection into mice.

Authors:  E A Weereratne; G Gregoriadis; J Crow
Journal:  Br J Exp Pathol       Date:  1983-12

6.  Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats.

Authors:  H Harashima; T M Huong; T Ishida; Y Manabe; H Matsuo; H Kiwada
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

Review 7.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.

Authors:  Terence Ta; Tyrone M Porter
Journal:  J Control Release       Date:  2013-04-11       Impact factor: 9.776

8.  Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.

Authors:  L D Mayer; R Nayar; R L Thies; N L Boman; P R Cullis; M B Bally
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  In vivo stability of ester- and ether-linked phospholipid-containing liposomes as measured by perturbed angular correlation spectroscopy.

Authors:  J T Derksen; J D Baldeschwieler; G L Scherphof
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 10.  Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.

Authors:  Francis Man; Peter J Gawne; Rafael T M de Rosales
Journal:  Adv Drug Deliv Rev       Date:  2019-06-03       Impact factor: 15.470

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.